There are 412 resources available
Introduction and first vote
Presenter: Javier Cortes
Session: Is low dose endocrine therapy the new standard for breast cancer chemo prevention?
Resources:
Slides
Webcast
Yes
Presenter: Andrea De Censi
Session: Is low dose endocrine therapy the new standard for breast cancer chemo prevention?
Resources:
Slides
Webcast
No
Presenter: Gareth Evans
Session: Is low dose endocrine therapy the new standard for breast cancer chemo prevention?
Resources:
Slides
Webcast
Second vote and conclusions/discussion
Presenter: Javier Cortes
Session: Is low dose endocrine therapy the new standard for breast cancer chemo prevention?
Resources:
Slides
Webcast
Managing short and long term toxicities of immuotherapy
Presenter: Ana Mafalda Antunes De Melo e Oliveira
Session: Management of toxicities of the most recent drugs in the breast cancer field
Resources:
Slides
Webcast
Methylome platform for multi-cancer early detection
Presenter: Heather Parsons
Session: ctDNA for clinical decision making
Resources:
Slides
Webcast
Clinical case 1: Optimal management of high - risk HR+/HER2- early breast cancer
Presenter: Anna Lea Amylidi
Session: YO Clinical case discussion
Resources:
Slides
Webcast
Liquid biopsy and minimal residual disease
Presenter: Klaus Pantel
Session: ctDNA for clinical decision making
Resources:
Slides
Webcast
Mentor guided discussion
Presenter: Eva Ciruelos
Session: YO Clinical case discussion
Resources:
Slides
Webcast
Insights into management of toxicities of ADCs including rechallenge
Presenter: Peter Schmid
Session: Management of toxicities of the most recent drugs in the breast cancer field
Resources:
Webcast